|
Volumn 17, Issue 3, 2017, Pages 511-520
|
A vascularized and perfused organ-on-a-chip platform for large-scale drug screening applications
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANGIOGENESIS INHIBITOR;
ANTINEOPLASTIC AGENT;
ANGIOGENESIS;
ARTICLE;
CONTROLLED STUDY;
DRUG DETERMINATION;
DRUG IDENTIFICATION;
DRUG SCREENING;
FLOW RATE;
HUMAN;
HUMAN CELL;
HYDROSTATIC PRESSURE;
LAB ON A CHIP;
PRIORITY JOURNAL;
CELL CULTURE TECHNIQUE;
DEVICES;
DRUG EFFECTS;
EQUIPMENT DESIGN;
EXPERIMENTAL NEOPLASM;
GENE EXPRESSION PROFILING;
GENE EXPRESSION REGULATION;
METABOLISM;
MICROFLUIDIC ANALYSIS;
NEOVASCULARIZATION (PATHOLOGY);
PRECLINICAL STUDY;
PROCEDURES;
TISSUE MICROARRAY;
ANTINEOPLASTIC AGENTS;
CELL CULTURE TECHNIQUES;
DRUG EVALUATION, PRECLINICAL;
EQUIPMENT DESIGN;
GENE EXPRESSION PROFILING;
GENE EXPRESSION REGULATION, NEOPLASTIC;
HUMANS;
MICROFLUIDIC ANALYTICAL TECHNIQUES;
NEOPLASMS, EXPERIMENTAL;
NEOVASCULARIZATION, PATHOLOGIC;
TISSUE ARRAY ANALYSIS;
|
EID: 85010977112
PISSN: 14730197
EISSN: 14730189
Source Type: Journal
DOI: 10.1039/c6lc01422d Document Type: Article |
Times cited : (262)
|
References (20)
|